HNRNPK and cancer: Mechanistic investigations on one of the top S-phase enriched cancer associated lncRNAs SCAT7 (ELF3-AS1) revealed that it promotes tumorigenesis through activating fibroblast growth factor (FGF/FGFR)-dependent PI3K/AKT and MAPK pro-survival pathways via interacting with hnRNPK/YBX1 complex [4].